Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$861M |
| 2 |
Apple
AAPL
|
+$417M |
| 3 |
JPMorgan Chase
JPM
|
+$350M |
| 4 |
T-Mobile US
TMUS
|
+$337M |
| 5 |
Aon
AON
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$603M |
| 2 |
Charter Communications
CHTR
|
+$504M |
| 3 |
Fidelity National Information Services
FIS
|
+$496M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$429M |
| 5 |
Baxter International
BAX
|
+$362M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.4% |
| 2 | Technology | 3.32% |
| 3 | Consumer Discretionary | 2.87% |
| 4 | Financials | 2.84% |
| 5 | Industrials | 2.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CALL
UnitedHealth
UNH
$361B
| $218M | 0.08% |
739,500
-78,500
| -10% | -$22.5M |
|
152
Aflac
AFL
$60.7B
| $218M | 0.08% |
6,045,757
+1,763,829
| +41% | +$63.7M |
|
153
CALL
ServiceNow
NOW
$132B
| $218M | 0.08% |
2,686,000
+682,500
| +34% | +$48.2M |
|
154
Citigroup
C
$228B
| $216M | 0.08% |
4,220,993
+4,127,260
| +4,403% | +$196M |
|
155
CALL
Regeneron Pharmaceuticals
REGN
$82.1B
| $215M | 0.08% |
344,500
-36,000
| -9% | -$20.4M |
|
156
CALL
Uber
UBER
$160B
| $214M | 0.08% |
6,888,200
+1,938,000
| +39% | +$60.4M |
|
157
PUT
iShares MSCI Emerging Markets ETF
EEM
$29.9B
| $211M | 0.08% |
5,279,700
-2,437,700
| -32% | -$91.3M |
|
158
Eli Lilly
LLY
$1.08T
| $210M | 0.08% |
1,281,655
+1,270,416
| +11,304% | +$195M |
|
159
PUT
Qualcomm
QCOM
$171B
| $210M | 0.07% |
2,300,200
+259,700
| +13% | +$20.8M |
|
160
Las Vegas Sands
LVS
$29.6B
| $206M | 0.07% |
4,528,112
+3,209,575
| +243% | +$151M |
|
161
PUT
Verizon
VZ
$196B
| $206M | 0.07% |
3,736,500
+1,555,500
| +71% | +$87.5M |
|
162
PUT
Nike
NKE
$61.3B
| $206M | 0.07% |
2,098,900
-143,700
| -6% | -$13.3M |
|
163
CALL
McDonald's
MCD
$194B
| $206M | 0.07% |
1,114,900
+174,600
| +19% | +$32M |
|
164
PUT
Zoom
ZM
$31.1B
| $206M | 0.07% |
811,100
+229,500
| +39% | +$41.3M |
|
|
HZNP
165
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $205M | 0.07% |
3,682,250
+84,598
| +2% | +$3.62M |
|
166
PUT
Beyond Meat
BYND
$215M
| $205M | 0.07% |
1,526,800
+588,700
| +63% | +$69.7M |
|
167
PUT
Roku
ROKU
$22.4B
| $204M | 0.07% |
1,754,700
+125,600
| +8% | +$14.4M |
|
168
PUT
Morgan Stanley
MS
$338B
| $204M | 0.07% |
4,226,400
+1,972,000
| +87% | +$82.8M |
|
|
SCHW
169
Charles Schwab
SCHW
$186B
| $203M | 0.07% |
6,022,911
+1,229,443
| +26% | +$44M |
|
170
CALL
Gilead Sciences
GILD
$168B
| $203M | 0.07% |
2,638,000
+232,100
| +10% | +$17.8M |
|
171
CALL
iShares China Large-Cap ETF
FXI
$4.25B
| $201M | 0.07% |
5,066,800
+2,548,200
| +101% | +$99.4M |
|
|
172
CALL
Citigroup
C
$228B
| $201M | 0.07% |
3,931,500
-1,282,200
| -25% | -$60.8M |
|
173
PUT
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $200M | 0.07% |
2,311,000
+1,706,000
| +282% | +$148M |
|
|
174
PUT
Regeneron Pharmaceuticals
REGN
$82.1B
| $199M | 0.07% |
318,400
-37,400
| -11% | -$21.2M |
|
175
CALL
Bank of America
BAC
$448B
| $198M | 0.07% |
8,343,700
-9,365,900
| -53% | -$221M |
|
Similar funds
Ken Griffin's Q2 2020 Portfolio in Review
As of Q2 2020, Ken Griffin held 11,014 positions worth $280B, up 26% from $222B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin withdrew a net $9.91B in Q2 2020, closing 1,324 positions and reducing 3,586 holdings. Its most notable exit was Allergan plc, an estimated $603M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.4% of assets, down from 4% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Becton Dickinson worth $266M.
- Ken Griffin's largest Q2 2020 buy was Becton Dickinson: 1,140,373 shares worth $266M.
- Ken Griffin added most to Amazon in Q2 2020, an estimated $861M increase.
- Ken Griffin's biggest Q2 2020 reduction was Charter Communications, cutting an estimated $504M.
- Ken Griffin fully exited Allergan plc in Q2 2020, selling an estimated $603M.
- Ken Griffin's ten largest holdings make up 32% of its $280B portfolio in Q2 2020.
- Ken Griffin opened 1,506 new positions and closed 1,324 in Q2 2020.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $280B.
Based on Citadel Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.